Axortex

The culture of tech, food & beauty

← Food
Food

Fermented Future: A Mycoprotein Win in the Alt-Protein Winter

A Dutch mycoprotein maker’s €18M raise — and a first-of-its-kind EU approval — buck the alt-protein gloom.

TL;DR — Dutch food-tech firm The Protein Brewery raised an €18 million Series B extension after its mycoprotein ingredient Fermotein became the first whole-food novel mycelium ingredient approved under the EU’s Novel Food Regulation — a bright spot in a tough alt-protein funding climate.

On June 29, 2026, a Dutch food-tech firm turned a regulatory first into fresh capital.

The raise

The Protein Brewery, based in Breda, Netherlands, closed an oversubscribed €18 million Series B extension led by the ABN AMRO Sustainable Impact Fund, bringing total funding above €70 million. The round follows a landmark milestone: its mycoprotein ingredient Fermotein (from the fungus Rhizomucor pusillus) became the first whole-food novel mycelium ingredient approved under the EU Novel Food Regulation, about two weeks earlier.

Detail
Raise €18M (Series B extension)
Total funding >€70M
Milestone First EU-approved whole-food mycelium
HQ Breda, Netherlands

What they said

"Building a completely new ingredient category takes patience and investment in the right activities, at the right time." — Thijs Bosch, CEO, The Protein Brewery

Why it matters

  • A bright spot in a downturn. Fermentation is drawing capital while plant-based startups struggle.
  • Regulatory unlock. EU novel-food approval clears a path to market across Europe.
  • Capital discipline. Investors are backing proof and approvals over 2021-era hype.

FAQ

What did The Protein Brewery raise, and why does it matter?

It closed an €18 million Series B extension on June 29, 2026 (total funding now above €70 million), shortly after its Fermotein mycoprotein became the first whole-food novel mycelium ingredient approved under the EU Novel Food Regulation — a key step to selling across Europe.

What is Fermotein?

Fermotein is a mycoprotein ingredient made from the fungus Rhizomucor pusillus via fermentation. Its EU Novel Food approval makes it, per the company, the first whole-food novel mycelium ingredient cleared under that regulation.

Sources

Image: “Mycelium in a petri dish” by Tobi Kellner, CC BY-SA 3.0, via Wikimedia Commons.

#alt-protein#mycoprotein#fermentation#eu-novel-food#food-tech#funding

← Back to all posts